National health insurance and the way leading to better diabetes care in Taiwan. Is there a role of comprehensive analyses of the claims data?  by Lai, Mei-Shu
Journal of the Formosan Medical Association (2012) 111, 587e588Available online at www.sciencedirect.com
journal homepage: www.jfma-onl ine.comPERSPECTIVES
National health insurance and the way leading
to better diabetes care in Taiwan. Is there a role
of comprehensive analyses of the claims data?Mei-Shu Lai*Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taiwan
Received 21 August 2012; received in revised form 23 August 2012; accepted 26 August 2012Type 2 diabetes has become an important public health
challenge in Asia, including Taiwan.1 By using the National
Health Insurance (NHI) claims data, Professor Chuang and
colleagues conducted a series of studies describing the
trends of prevalence, incidence, mortality, treatment
patterns, comorbid diseases, and complications of diabetes
mellitus during the past decade.2 The authors found that,
despite a nearly 25% increase in the overall diabetes inci-
dence, the mortality for diabetic men and women
decreased from 2000 to 2009. Although there is an
increasing prevalence of patients with diabetic kidney, eye,
and foot disease, as well as patients having concomitant
hypertension and hyperlipidemia, the number of patients
with limb amputation was declining. The frequency of
annual check-up of various metabolic parameters and the
complexity of anti-diabetic therapy also increased during
the past 10 years. These data provide the benchmark to
refine the health policy for the prevention, screening, and
treatment of diabetes in Taiwan.
Taiwan’s NHI program, started since 1995, provides
healthcare services with the highest coverage rate, most
comprehensive benefits, and the highest accessibility than
any other countries in the world. The Taiwan NHI claims
database has become the most important healthcare* Corresponding author. Institute of Epidemiology and Preventive
Medicine, College of Public Health, National Taiwan University,
Taiwan.
E-mail address: mslai@ntu.edu.tw.
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research analyzing the NHI claims database have been
published that help us understand the epidemiology,
disease burden, outcomes, and treatment patterns of
several important diseases, including type 2 diabetes.2,3 As
compared with data from surveys (such as Nutrition and
Health Survey 1993e1996 and the 2002 Survey on the
Prevalence of Hypertension, Hyperglycemia and Hyperlip-
idemia in Taiwan) and several small population studies
conducted in the 1990s,4e6 the NHI claims database is
a valuable resource for estimating chronic disease burdens,
care pattern, drug utilization and adherence, and medical
expenditure because of its nationwide representativeness,
large sample size, low cost, and its capability of providing
continuous trends in terms of longitudinal follow-up.
However, there are concerns about using healthcare
claims data for epidemiologic research. First, there is
uncertainty about the validity of the diagnosis in the claims
database. The accuracy of diabetes diagnosis in NHI claims
data has been validated by a study sampling 9000 patients
with a diagnosis of diabetes in 2000.7 The authors demon-
strated that the positive predictive value can be increased
from approximately 60% to 90% by increasing the number of
outpatient diabetes diagnoses. Similarly, the accuracy of
diagnosis codes for comorbidities and diabetes-related
complications needed to be validated in NHI data.
Second, there is no clinical information such as body
weight, blood pressure, glycemic level, smoking, and life-
style factors in the NHI claims database. This will be
a major threat to study validity, particularly in the setting& Formosan Medical Association. All rights reserved.
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failure to control for them will inevitably lead to erroneous
results.
Due to the successes in public health improvement
during the past few decades and rapid urbanization, Taiwan
is transitioning from a traditional society to one with
rapidly increasing numbers of middle-aged and elderly
people with a chronic disease dominating pattern. Although
the implementation of NHI achieves a state with equal
accessibility to health care system, we are facing new
challenges in quality of care and efficiency of the payment.
The Taiwanese government is actively involved in the
healthcare system reform and dealt with quality as
a system property. There is a blooming of quality
improvement activities going on in Taiwan and many of
them involve diabetes patient management. Trying to
improve the quality of diabetic care, Taiwan established
practice guidelines for diabetic care, implemented
accreditation for diabetes care institutions, and set up
shared care networks in 25 counties.8 The professional
accountability, presented by frequency of laboratory
monitoring for diabetic patients, was widely accepted as an
indicator of quality assessment for diabetes care in process
domain.9 These quality measures were adopted by the
Taiwan Quality Improvement Program for internal
accountability comparison, and were presented on the
website for transparency. Since 2001, the Bureau of NHI has
implemented a Pay-for-Performance (P4P) program for
diabetes, which emphasizes a chronic care model with
multi-disciplinary care team and provides financial incen-
tives for healthcare providers to increase regular follow-up
visits including enhanced self-care education and compre-
hensive diabetes-specific assessment.10 A preliminary study
showed that the diabetes P4P program was associated with
a significant increase in outpatient follow-up visits and
evidence-based services, higher overall costs, but signifi-
cantly lower hospitalization costs.10 Further research is
needed to evaluate the policy impact of nationwide P4P
program on diabetic patient care, in particular patient
outcome and patient-perceived care quality.
Diabetes will inevitably continue to have a major impact
on our healthcare system in the next decade. There are still
many questions to be answered. For example, what is the
effectiveness in the primary prevention program against
diabetes and related complications, such as cardiovascular,
cerebrovascular, eye and kidney diseases? What are the
quality and efficiency of our care while taking costs andresource use into consideration? Is there any potential
overtreatment, inappropriate treatment, or even harm?
Are there any health disparities and geographic variations
in care? Are our patients satisfied with the services we
provide? Based on the valuable results from these nation-
wide studies published in this special issue of the journal
lead by the Diabetes Association of the R.O.C., it is a good
time to re-examine our strategies against diabetes and to
strengthen current share-care national network with better
care model with improved efficiency and cost-
effectiveness.References
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